The US Centers for Disease Control and Prevention (CDC) today updated its recommendations for testing pregnant women for Zika virus, mainly because one of the most frequently used tests—which detected immunoglobulin B (IgM) antibodies—is more likely to yield a false positive result, especially as incidence of the disease in the Americas decreases.
The US Centers for Disease Control and Prevention (CDC) today announced a multistate Salmonella Typhimurium outbreak linked to microbiology laboratories that has sickened 24 people in 16 states. The infections have been associated with clinical, commercial, and teaching labs.
Babies living in countries affected by conflict made up more than half of the total of unvaccinated group.
Monitoring of contacts identified in three recent MERS-CoV hospital clusters in Riyadh, Saudi Arabia, ended on Jun 30, and no other cases have been detected, keeping the total number of people infected in the recent outbreaks to 49, the World Health Organization (WHO) said today in an update on the disease.
A second case of vaccine-derived polio is reported in Raqqa, Syria, while a Pakistani toddler has a wild poliovirus infection.
The new vaccine-derived cases lift the outbreak total to 22, all but 1 in Deir ez-Zor governorate.
Syria has confirmed 15 additional cases of polio, including 1 case in a child who may have contracted the disease in Raqqa, a city held by the terrorist group ISIS, Reuters reported today.
Two cases were announced in Syria earlier this month, the first since 2014, so the total has now reachaed 17 cases, with symptom onset ranging from Mar 3 to May 23. All 17 cases involve paralysis.
Today the Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV related to ongoing outbreaks in three Riyadh hospitals.
A 68-year-old male expatriate who had preexisting disease has died from MERS-CoV (Middle East respiratory syndrome coronavirus). He acquired the virus as a patient in a hospital.
The WHO says the 2 vaccine-derived clusters in the DRC involve 2 separate strains.
In a new study on the Ebola vaccine that has already shown effectiveness in an earlier phase 3 trial during West Africa's outbreak, researchers found that antibodies persist at least for a year and that the vaccine was well tolerated.
